Journal
Gynecologic Oncology
Publication Date
3-1-2025
Volume
194
First Page
71
Last Page
79
Document Type
Open Access Publication
DOI
10.1016/j.ygyno.2025.02.010
Rights and Permissions
Alvero AB, Wu S, Farrell A, Kim S, Wallbillich JJ, Winer I, Morris R, Spetzler D, Anderson ML, Puccini A, Jones NL, Herzog TJ, Thaker PH, Mor G, Gogoi RP. Exploring the differences between BRCA mutated and HRwild-type high grade serous ovarian cancer: A multiomic analysis. Gynecol Oncol. 2025 Mar;194:71-79. doi: 10.1016/j.ygyno.2025.02.010. © 2025 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/).
Recommended Citation
Alvero, Ayesha B; Wu, Sharon; Farrell, Alex; Kim, Seongho; Wallbillich, John J; Winer, Ira; Morris, Robert; Spetzler, David; Anderson, Matthew L; Puccini, Alberto; Jones, Nathaniel L; Herzog, Thomas J; Thaker, Premal H; Mor, Gil; and Gogoi, Radhika P, "Exploring the differences between BRCA mutated and HRwild-type high grade serous ovarian cancer: A multiomic analysis." Gynecologic Oncology. 194, 71 - 79. (2025).
https://digitalcommons.wustl.edu/oa_4/5845
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
